{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:20:19Z","timestamp":1787530819696,"version":"build-2736575974"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02948-2","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:01:45Z","timestamp":1787529705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond prostate-specific antigen: ctDNA as an early compass for treatment adaptation in metastatic prostate cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Giandomenico","family":"Roviello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Antonuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"2948_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s43018-026-01172-9","volume":"7","author":"A Jayaram","year":"2026","unstructured":"Jayaram, A. et al. Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study. Nat. Cancer 7, 915\u2013927 (2026).","journal-title":"Nat. Cancer"},{"key":"2948_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-03041-4","volume":"42","author":"IW Mutalip","year":"2025","unstructured":"Mutalip, I. W., Barth, A. F., Sellers, G. S., Wakefield, M. R. & Fang, Y. From bench to bedside: the evolution and future of prostate-specific antigen testing. Med. Oncol. 42, 486 (2025).","journal-title":"Med. Oncol."},{"key":"2948_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-025-00540-y","volume":"11","author":"S Zhao","year":"2025","unstructured":"Zhao, S. et al. Evaluating PSA dynamics for predicting androgen deprivation failure with a patient specific prostate cancer model. npj Syst. Biol. Appl. 11, 59 (2025).","journal-title":"npj Syst. Biol. Appl."},{"key":"2948_CR4","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/cancers18111702","volume":"18","author":"B Thapa","year":"2026","unstructured":"Thapa, B., Venturini, J., Choudhury, A. D. & Francini, E. Circulating tumor DNA as emerging predictive and prognostic biomarker in prostate cancer. Cancers 18, 1702 (2026).","journal-title":"Cancers"},{"key":"2948_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00876-y","volume":"9","author":"A Bartolomucci","year":"2025","unstructured":"Bartolomucci, A. et al. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology. npj Precis. Oncol. 9, 84 (2025).","journal-title":"npj Precis. Oncol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02948-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02948-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02948-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:01:46Z","timestamp":1787529706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02948-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02948-2","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"342"}}